Promising Results for Chemo-Free Immunotherapy in Early-Stage Triple-Negative Breast Cancer
Phase 2 trial shows potential for immunotherapy without chemo in early TNBC, especially with high TILs.
87 articles
(Page 5)
FLAURA2 Trial: Osimertinib Plus Chemo Boosts Survival in EGFR-Mutated Lung Cancer
Combining osimertinib with chemotherapy significantly improves progression-free survival in NSCLC patients.
Vitamin D Deficiency Linked to Increased Chemotherapy Side Effects in Breast Cancer Patients
Study finds vitamin D insufficiency may raise risk of chemotherapy-induced neuropathy in breast cancer.
New Bladder Cancer Treatment Slashes Recurrence Rates: Promising Results from Egyptian Trial
Study shows neoadjuvant EMDA of mitomycin C before TURBT may reduce bladder cancer recurrence vs BCG alone.
SOLAR Trial: Revolutionizing Rectal Cancer Treatment with Short-Course Radiotherapy
New trial compares short-course radiotherapy plus chemotherapy to standard chemoradiotherapy for rectal cancer
SYNERGY Trial: Oleclumab Falls Short in Boosting TNBC Chemo-Immunotherapy
Phase I/II trial shows adding oleclumab to standard therapy doesn't improve outcomes in advanced TNBC.
ATRA Boosts FOLFOX4 Efficacy in Advanced Liver Cancer with Metastasis
Study shows FOLFOX4 + ATRA improves survival in advanced hepatocellular carcinoma with metastasis
New Hope for Acute Myeloid Leukemia: Cusatuzumab Shows Promise in Clinical Trial
Cusatuzumab plus azacitidine shows efficacy in treating newly diagnosed acute myeloid leukemia
Decitabine vs. Standard Chemo: A New Approach for Older AML Patients
Study compares 10-day decitabine to standard chemo for older AML patients eligible for transplant
Breakthrough Treatment Combo Shows Promise for HER2+ Metastatic Breast Cancer
Novel drug combination significantly improves progression-free survival in HER2+ metastatic breast cancer
New Drug Combo Falls Short in Ovarian Cancer Trial
Phase III trial of ofranergene obadenovec plus paclitaxel fails to improve outcomes in ovarian cancer
Fosfomycin vs Ciprofloxacin: A New Approach to Prevent Infections in High-Risk Blood Cancer Patients
Study compares fosfomycin to ciprofloxacin for preventing infections in leukemia and transplant patients
Pembrolizumab Plus Chemo Boosts Survival in Advanced Gastric Cancer
Study shows pembrolizumab with chemotherapy improves outcomes in HER2-negative gastric cancer